Imagine you are stepping in as CEO of your company and your executive strategy team presents you with a new strategy they have been working on for well over a year. The problem is the number of initiatives they have included don’t match your budget constraints. Do you simply make decisions at the top and inform the company? Do you ask a broader but still limited contingent of stakeholders? Or do you include everyone?
This was the exact dilemma faced by Thomas Schinecker, the CEO of Roche Diagnostics, CPS. He took what some might consider the more daunting option and went for total inclusion. Here is how he did it:
BOOST: Building Our Organization Strategy Together
Step one: the company held workshops across several locations with all employees invited to contribute.
Step two: a think tank…